UBS Chief European Equity Strategist and Head of Derivates Gerry Fowler discusses the factors behind the tech selloff and where he sees value in markets. "You're going to get volatility — this isn't the first time we've seen this," Fowler tells Bloomberg Television. "It's an artifice of market structure that I suspect is not going away." (Source: Bloomberg)
UBS Chief European Equity Strategist and Head of Derivates Gerry Fowler discusses the factors behind the tech selloff and where he sees value in markets. "You're going to get volatility — this isn't the first time we've seen this," Fowler tells Bloomberg Television. "It's an artifice of market structure that I suspect is not going away." (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/42b3fc66a057c81ce391626840fe570268e66280" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="UBS' Fowler Sees Value in US Cyclicals, Pharmaceuticals"></iframe>
